Loading…

Functional imaging of tumor vasculature using iodine and gadolinium-based nanoparticle contrast agents: a comparison of spectral micro-CT using energy integrating and photon counting detectors

Advances in computed tomography (CT) hardware have propelled the development of novel CT contrast agents. In particular, the spectral capabilities of x-ray CT can facilitate simultaneous imaging of multiple contrast agents. This approach is particularly useful for functional imaging of solid tumors...

Full description

Saved in:
Bibliographic Details
Published in:Physics in medicine & biology 2019-03, Vol.64 (6), p.065007-065007
Main Authors: Badea, C T, Clark, D P, Holbrook, M, Srivastava, M, Mowery, Y, Ghaghada, K B
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c433t-941515f5eed42751091ace8371e24e6fe8677a3cf1b8181d513735e0866bd3773
cites cdi_FETCH-LOGICAL-c433t-941515f5eed42751091ace8371e24e6fe8677a3cf1b8181d513735e0866bd3773
container_end_page 065007
container_issue 6
container_start_page 065007
container_title Physics in medicine & biology
container_volume 64
creator Badea, C T
Clark, D P
Holbrook, M
Srivastava, M
Mowery, Y
Ghaghada, K B
description Advances in computed tomography (CT) hardware have propelled the development of novel CT contrast agents. In particular, the spectral capabilities of x-ray CT can facilitate simultaneous imaging of multiple contrast agents. This approach is particularly useful for functional imaging of solid tumors by simultaneous visualization of multiple targets or architectural features that govern cancer development and progression. Nanoparticles are a promising platform for contrast agent development. While several novel imaging moieties based on high atomic number elements are being explored, iodine (I) and gadolinium (Gd) are particularly attractive because of their existing approval for clinical use. In this work, we investigate the in vivo discrimination of I and Gd nanoparticle contrast agents using both dual energy micro-CT with energy integrating detectors (DE-EID) and photon counting detector (PCD)-based spectral micro-CT. Simulations and phantom experiments were performed using varying concentrations of I and Gd to determine the imaging performance with optimized acquisition parameters. Quantitative spectral micro-CT imaging using liposomal-iodine (Lip-I) and liposomal-Gd (Lip-Gd) nanoparticle contrast agents was performed in sarcoma bearing mice for anatomical and functional imaging of tumor vasculature. Iterative reconstruction provided high sensitivity to detect and discriminate relatively low I and Gd concentrations. According to the Rose criterion applied to the experimental results, the detectability limits for I and Gd were approximately 2.5 mg ml−1 for both DE-EID CT and PCD micro-CT, even if the radiation dose was approximately 3.8 times lower with PCD micro-CT. The material concentration maps confirmed expected biodistributions of contrast agents in the blood, liver, spleen and kidneys. The PCD provided lower background signal and better simultaneous visualization of tumor vasculature and intratumoral distribution patterns of nanoparticle contrast agent compared to DE-EID decompositions. Preclinical spectral CT systems such as this could be useful for functional characterization of solid tumors, simultaneous quantitative imaging of multiple targets and for identifying clinically-relevant applications that benefit from the use of spectral imaging. Additionally, it could aid in the development nanoparticles that show promise in the developing field of cancer theranostics (therapy and diagnostics) by measuring vascular tumor biomarkers such as fraction
doi_str_mv 10.1088/1361-6560/ab03e2
format article
fullrecord <record><control><sourceid>pubmed_iop_j</sourceid><recordid>TN_cdi_pubmed_primary_30708357</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>30708357</sourcerecordid><originalsourceid>FETCH-LOGICAL-c433t-941515f5eed42751091ace8371e24e6fe8677a3cf1b8181d513735e0866bd3773</originalsourceid><addsrcrecordid>eNp1UU1rFDEYDmKx2-rdk-QHOG2ymXysB0EWW4WCl_YcMsk705SZZEgyhf67_jQz3browVPg-eTNg9BHSi4oUeqSMkEbwQW5NB1hsH2DNkfoLdoQwmizo5yforOcHwihVG3bd-iUEUkU43KDnq-WYIuPwYzYT2bwYcCxx2WZYsKPJttlNGVJgJe8Uj46HwCb4PBgXBx98MvUdCaDw8GEOJtUvB0B2xhKMrlgM0Ao-Qs2FZoq7XMMa0OewVbFiCdvU2z2t68NECANT9iHAkMyZYXWtvk-lmq0cQkvmINS_THl9-ikN2OGD6_vObq7-n67_9Hc_Lr-uf9209iWsdLsWsop7zmAa7eSU7KjxoJiksK2BdGDElIaZnvaKaqo45RJxoEoITrHpGTn6Oshd166CZyF9b5Rz6n-WnrS0Xj9LxP8vR7ioxaCyLYlNYAcAuq5OSfoj15K9LqmXqfT63T6sGa1fPq782j4M18VfD4IfJz1Q1xSnTH_P-83RzSvrw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Functional imaging of tumor vasculature using iodine and gadolinium-based nanoparticle contrast agents: a comparison of spectral micro-CT using energy integrating and photon counting detectors</title><source>Institute of Physics</source><creator>Badea, C T ; Clark, D P ; Holbrook, M ; Srivastava, M ; Mowery, Y ; Ghaghada, K B</creator><creatorcontrib>Badea, C T ; Clark, D P ; Holbrook, M ; Srivastava, M ; Mowery, Y ; Ghaghada, K B</creatorcontrib><description>Advances in computed tomography (CT) hardware have propelled the development of novel CT contrast agents. In particular, the spectral capabilities of x-ray CT can facilitate simultaneous imaging of multiple contrast agents. This approach is particularly useful for functional imaging of solid tumors by simultaneous visualization of multiple targets or architectural features that govern cancer development and progression. Nanoparticles are a promising platform for contrast agent development. While several novel imaging moieties based on high atomic number elements are being explored, iodine (I) and gadolinium (Gd) are particularly attractive because of their existing approval for clinical use. In this work, we investigate the in vivo discrimination of I and Gd nanoparticle contrast agents using both dual energy micro-CT with energy integrating detectors (DE-EID) and photon counting detector (PCD)-based spectral micro-CT. Simulations and phantom experiments were performed using varying concentrations of I and Gd to determine the imaging performance with optimized acquisition parameters. Quantitative spectral micro-CT imaging using liposomal-iodine (Lip-I) and liposomal-Gd (Lip-Gd) nanoparticle contrast agents was performed in sarcoma bearing mice for anatomical and functional imaging of tumor vasculature. Iterative reconstruction provided high sensitivity to detect and discriminate relatively low I and Gd concentrations. According to the Rose criterion applied to the experimental results, the detectability limits for I and Gd were approximately 2.5 mg ml−1 for both DE-EID CT and PCD micro-CT, even if the radiation dose was approximately 3.8 times lower with PCD micro-CT. The material concentration maps confirmed expected biodistributions of contrast agents in the blood, liver, spleen and kidneys. The PCD provided lower background signal and better simultaneous visualization of tumor vasculature and intratumoral distribution patterns of nanoparticle contrast agent compared to DE-EID decompositions. Preclinical spectral CT systems such as this could be useful for functional characterization of solid tumors, simultaneous quantitative imaging of multiple targets and for identifying clinically-relevant applications that benefit from the use of spectral imaging. Additionally, it could aid in the development nanoparticles that show promise in the developing field of cancer theranostics (therapy and diagnostics) by measuring vascular tumor biomarkers such as fractional blood volume and the delivery of liposomal chemotherapeutics.</description><identifier>ISSN: 0031-9155</identifier><identifier>EISSN: 1361-6560</identifier><identifier>DOI: 10.1088/1361-6560/ab03e2</identifier><identifier>PMID: 30708357</identifier><identifier>CODEN: PHMBA7</identifier><language>eng</language><publisher>England: IOP Publishing</publisher><subject>Animals ; cancer ; computed tomography ; Contrast Media ; Gadolinium - metabolism ; Humans ; Iodine - metabolism ; liposomes ; Magnetic Resonance Imaging ; Mice ; Mice, Inbred C57BL ; nanoparticles ; Nanoparticles - chemistry ; Neovascularization, Pathologic ; Phantoms, Imaging ; photon counting detector ; Photons ; preclinical ; Sarcoma - blood supply ; Sarcoma - diagnostic imaging ; Sarcoma - metabolism ; Sarcoma - pathology ; spectral ; Tomography Scanners, X-Ray Computed ; X-Ray Microtomography - instrumentation ; X-Ray Microtomography - methods</subject><ispartof>Physics in medicine &amp; biology, 2019-03, Vol.64 (6), p.065007-065007</ispartof><rights>2019 Institute of Physics and Engineering in Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c433t-941515f5eed42751091ace8371e24e6fe8677a3cf1b8181d513735e0866bd3773</citedby><cites>FETCH-LOGICAL-c433t-941515f5eed42751091ace8371e24e6fe8677a3cf1b8181d513735e0866bd3773</cites><orcidid>0000-0002-5832-8725 ; 0000-0002-1850-2522</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30708357$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Badea, C T</creatorcontrib><creatorcontrib>Clark, D P</creatorcontrib><creatorcontrib>Holbrook, M</creatorcontrib><creatorcontrib>Srivastava, M</creatorcontrib><creatorcontrib>Mowery, Y</creatorcontrib><creatorcontrib>Ghaghada, K B</creatorcontrib><title>Functional imaging of tumor vasculature using iodine and gadolinium-based nanoparticle contrast agents: a comparison of spectral micro-CT using energy integrating and photon counting detectors</title><title>Physics in medicine &amp; biology</title><addtitle>PMB</addtitle><addtitle>Phys. Med. Biol</addtitle><description>Advances in computed tomography (CT) hardware have propelled the development of novel CT contrast agents. In particular, the spectral capabilities of x-ray CT can facilitate simultaneous imaging of multiple contrast agents. This approach is particularly useful for functional imaging of solid tumors by simultaneous visualization of multiple targets or architectural features that govern cancer development and progression. Nanoparticles are a promising platform for contrast agent development. While several novel imaging moieties based on high atomic number elements are being explored, iodine (I) and gadolinium (Gd) are particularly attractive because of their existing approval for clinical use. In this work, we investigate the in vivo discrimination of I and Gd nanoparticle contrast agents using both dual energy micro-CT with energy integrating detectors (DE-EID) and photon counting detector (PCD)-based spectral micro-CT. Simulations and phantom experiments were performed using varying concentrations of I and Gd to determine the imaging performance with optimized acquisition parameters. Quantitative spectral micro-CT imaging using liposomal-iodine (Lip-I) and liposomal-Gd (Lip-Gd) nanoparticle contrast agents was performed in sarcoma bearing mice for anatomical and functional imaging of tumor vasculature. Iterative reconstruction provided high sensitivity to detect and discriminate relatively low I and Gd concentrations. According to the Rose criterion applied to the experimental results, the detectability limits for I and Gd were approximately 2.5 mg ml−1 for both DE-EID CT and PCD micro-CT, even if the radiation dose was approximately 3.8 times lower with PCD micro-CT. The material concentration maps confirmed expected biodistributions of contrast agents in the blood, liver, spleen and kidneys. The PCD provided lower background signal and better simultaneous visualization of tumor vasculature and intratumoral distribution patterns of nanoparticle contrast agent compared to DE-EID decompositions. Preclinical spectral CT systems such as this could be useful for functional characterization of solid tumors, simultaneous quantitative imaging of multiple targets and for identifying clinically-relevant applications that benefit from the use of spectral imaging. Additionally, it could aid in the development nanoparticles that show promise in the developing field of cancer theranostics (therapy and diagnostics) by measuring vascular tumor biomarkers such as fractional blood volume and the delivery of liposomal chemotherapeutics.</description><subject>Animals</subject><subject>cancer</subject><subject>computed tomography</subject><subject>Contrast Media</subject><subject>Gadolinium - metabolism</subject><subject>Humans</subject><subject>Iodine - metabolism</subject><subject>liposomes</subject><subject>Magnetic Resonance Imaging</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>nanoparticles</subject><subject>Nanoparticles - chemistry</subject><subject>Neovascularization, Pathologic</subject><subject>Phantoms, Imaging</subject><subject>photon counting detector</subject><subject>Photons</subject><subject>preclinical</subject><subject>Sarcoma - blood supply</subject><subject>Sarcoma - diagnostic imaging</subject><subject>Sarcoma - metabolism</subject><subject>Sarcoma - pathology</subject><subject>spectral</subject><subject>Tomography Scanners, X-Ray Computed</subject><subject>X-Ray Microtomography - instrumentation</subject><subject>X-Ray Microtomography - methods</subject><issn>0031-9155</issn><issn>1361-6560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1UU1rFDEYDmKx2-rdk-QHOG2ymXysB0EWW4WCl_YcMsk705SZZEgyhf67_jQz3browVPg-eTNg9BHSi4oUeqSMkEbwQW5NB1hsH2DNkfoLdoQwmizo5yforOcHwihVG3bd-iUEUkU43KDnq-WYIuPwYzYT2bwYcCxx2WZYsKPJttlNGVJgJe8Uj46HwCb4PBgXBx98MvUdCaDw8GEOJtUvB0B2xhKMrlgM0Ao-Qs2FZoq7XMMa0OewVbFiCdvU2z2t68NECANT9iHAkMyZYXWtvk-lmq0cQkvmINS_THl9-ikN2OGD6_vObq7-n67_9Hc_Lr-uf9209iWsdLsWsop7zmAa7eSU7KjxoJiksK2BdGDElIaZnvaKaqo45RJxoEoITrHpGTn6Oshd166CZyF9b5Rz6n-WnrS0Xj9LxP8vR7ioxaCyLYlNYAcAuq5OSfoj15K9LqmXqfT63T6sGa1fPq782j4M18VfD4IfJz1Q1xSnTH_P-83RzSvrw</recordid><startdate>20190312</startdate><enddate>20190312</enddate><creator>Badea, C T</creator><creator>Clark, D P</creator><creator>Holbrook, M</creator><creator>Srivastava, M</creator><creator>Mowery, Y</creator><creator>Ghaghada, K B</creator><general>IOP Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5832-8725</orcidid><orcidid>https://orcid.org/0000-0002-1850-2522</orcidid></search><sort><creationdate>20190312</creationdate><title>Functional imaging of tumor vasculature using iodine and gadolinium-based nanoparticle contrast agents: a comparison of spectral micro-CT using energy integrating and photon counting detectors</title><author>Badea, C T ; Clark, D P ; Holbrook, M ; Srivastava, M ; Mowery, Y ; Ghaghada, K B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c433t-941515f5eed42751091ace8371e24e6fe8677a3cf1b8181d513735e0866bd3773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>cancer</topic><topic>computed tomography</topic><topic>Contrast Media</topic><topic>Gadolinium - metabolism</topic><topic>Humans</topic><topic>Iodine - metabolism</topic><topic>liposomes</topic><topic>Magnetic Resonance Imaging</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>nanoparticles</topic><topic>Nanoparticles - chemistry</topic><topic>Neovascularization, Pathologic</topic><topic>Phantoms, Imaging</topic><topic>photon counting detector</topic><topic>Photons</topic><topic>preclinical</topic><topic>Sarcoma - blood supply</topic><topic>Sarcoma - diagnostic imaging</topic><topic>Sarcoma - metabolism</topic><topic>Sarcoma - pathology</topic><topic>spectral</topic><topic>Tomography Scanners, X-Ray Computed</topic><topic>X-Ray Microtomography - instrumentation</topic><topic>X-Ray Microtomography - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Badea, C T</creatorcontrib><creatorcontrib>Clark, D P</creatorcontrib><creatorcontrib>Holbrook, M</creatorcontrib><creatorcontrib>Srivastava, M</creatorcontrib><creatorcontrib>Mowery, Y</creatorcontrib><creatorcontrib>Ghaghada, K B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Physics in medicine &amp; biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Badea, C T</au><au>Clark, D P</au><au>Holbrook, M</au><au>Srivastava, M</au><au>Mowery, Y</au><au>Ghaghada, K B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functional imaging of tumor vasculature using iodine and gadolinium-based nanoparticle contrast agents: a comparison of spectral micro-CT using energy integrating and photon counting detectors</atitle><jtitle>Physics in medicine &amp; biology</jtitle><stitle>PMB</stitle><addtitle>Phys. Med. Biol</addtitle><date>2019-03-12</date><risdate>2019</risdate><volume>64</volume><issue>6</issue><spage>065007</spage><epage>065007</epage><pages>065007-065007</pages><issn>0031-9155</issn><eissn>1361-6560</eissn><coden>PHMBA7</coden><abstract>Advances in computed tomography (CT) hardware have propelled the development of novel CT contrast agents. In particular, the spectral capabilities of x-ray CT can facilitate simultaneous imaging of multiple contrast agents. This approach is particularly useful for functional imaging of solid tumors by simultaneous visualization of multiple targets or architectural features that govern cancer development and progression. Nanoparticles are a promising platform for contrast agent development. While several novel imaging moieties based on high atomic number elements are being explored, iodine (I) and gadolinium (Gd) are particularly attractive because of their existing approval for clinical use. In this work, we investigate the in vivo discrimination of I and Gd nanoparticle contrast agents using both dual energy micro-CT with energy integrating detectors (DE-EID) and photon counting detector (PCD)-based spectral micro-CT. Simulations and phantom experiments were performed using varying concentrations of I and Gd to determine the imaging performance with optimized acquisition parameters. Quantitative spectral micro-CT imaging using liposomal-iodine (Lip-I) and liposomal-Gd (Lip-Gd) nanoparticle contrast agents was performed in sarcoma bearing mice for anatomical and functional imaging of tumor vasculature. Iterative reconstruction provided high sensitivity to detect and discriminate relatively low I and Gd concentrations. According to the Rose criterion applied to the experimental results, the detectability limits for I and Gd were approximately 2.5 mg ml−1 for both DE-EID CT and PCD micro-CT, even if the radiation dose was approximately 3.8 times lower with PCD micro-CT. The material concentration maps confirmed expected biodistributions of contrast agents in the blood, liver, spleen and kidneys. The PCD provided lower background signal and better simultaneous visualization of tumor vasculature and intratumoral distribution patterns of nanoparticle contrast agent compared to DE-EID decompositions. Preclinical spectral CT systems such as this could be useful for functional characterization of solid tumors, simultaneous quantitative imaging of multiple targets and for identifying clinically-relevant applications that benefit from the use of spectral imaging. Additionally, it could aid in the development nanoparticles that show promise in the developing field of cancer theranostics (therapy and diagnostics) by measuring vascular tumor biomarkers such as fractional blood volume and the delivery of liposomal chemotherapeutics.</abstract><cop>England</cop><pub>IOP Publishing</pub><pmid>30708357</pmid><doi>10.1088/1361-6560/ab03e2</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-5832-8725</orcidid><orcidid>https://orcid.org/0000-0002-1850-2522</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0031-9155
ispartof Physics in medicine & biology, 2019-03, Vol.64 (6), p.065007-065007
issn 0031-9155
1361-6560
language eng
recordid cdi_pubmed_primary_30708357
source Institute of Physics
subjects Animals
cancer
computed tomography
Contrast Media
Gadolinium - metabolism
Humans
Iodine - metabolism
liposomes
Magnetic Resonance Imaging
Mice
Mice, Inbred C57BL
nanoparticles
Nanoparticles - chemistry
Neovascularization, Pathologic
Phantoms, Imaging
photon counting detector
Photons
preclinical
Sarcoma - blood supply
Sarcoma - diagnostic imaging
Sarcoma - metabolism
Sarcoma - pathology
spectral
Tomography Scanners, X-Ray Computed
X-Ray Microtomography - instrumentation
X-Ray Microtomography - methods
title Functional imaging of tumor vasculature using iodine and gadolinium-based nanoparticle contrast agents: a comparison of spectral micro-CT using energy integrating and photon counting detectors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T14%3A17%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_iop_j&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functional%20imaging%20of%20tumor%20vasculature%20using%20iodine%20and%20gadolinium-based%20nanoparticle%20contrast%20agents:%20a%20comparison%20of%20spectral%20micro-CT%20using%20energy%20integrating%20and%20photon%20counting%20detectors&rft.jtitle=Physics%20in%20medicine%20&%20biology&rft.au=Badea,%20C%20T&rft.date=2019-03-12&rft.volume=64&rft.issue=6&rft.spage=065007&rft.epage=065007&rft.pages=065007-065007&rft.issn=0031-9155&rft.eissn=1361-6560&rft.coden=PHMBA7&rft_id=info:doi/10.1088/1361-6560/ab03e2&rft_dat=%3Cpubmed_iop_j%3E30708357%3C/pubmed_iop_j%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c433t-941515f5eed42751091ace8371e24e6fe8677a3cf1b8181d513735e0866bd3773%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/30708357&rfr_iscdi=true